Bingo! Dr. JL has his own professional life outside of his many years of expertise in, and work with, Leronlimab/CytoDyn. I'd love to see him as CEO permanently, but I get the interim tag. I think his presence will actually attract a quality individual to seriously consider taking over after him as opposed to taking over after the people who have provided the history we've endured.

We longs should all be thankful (intentional wording) that he is stepping into this leadership role for many reasons, but consider everything we are getting with him and then consider the terms he agreed to: the minimum pay that can be awarded by law, forgoing any bonus, and forgoing any equity compensation. WOW! We will look back at this day and say, "That was the day things really turned around."